Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures
1 other identifier
interventional
278
1 country
1
Brief Summary
The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2024
CompletedFirst Submitted
Initial submission to the registry
June 26, 2024
CompletedFirst Posted
Study publicly available on registry
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedAugust 20, 2026
August 1, 2026
1.5 years
June 26, 2024
August 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Identifying Outcomes of 40 hz, 50 hz and 60 hz laser setting groups during Holmium Laser Enucleation of the Prostate.
Comparing operative outcomes between the 40 hz, 50 hz and 60 hz laser setting groups.
2 years
Study Arms (3)
2J 40hz Laser Energy
EXPERIMENTALPatients will under go their Holmium Laser Enucleation procedure with the laser setting: 2J 40hz
2J 50hz Laser Energy
EXPERIMENTALPatients will under go their Holmium Laser Enucleation procedure with the laser setting: 2J 50hz
2J 60hz Laser Energy
EXPERIMENTALPatients will under go their Holmium Laser Enucleation procedure with the laser setting: 2J 60hz
Interventions
Patients will be randomized to one of the laser energy groups day of surgery.
Eligibility Criteria
You may qualify if:
- Males 18-89 who are undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms, that are typically caused by enlarged prostates
You may not qualify if:
- Prostates measurements over 200g
- Patients who lack decisional capacity
- Patients who are non-english speakers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern Medicine
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Krambeck, MD
Northwestern University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Urologic Surgeon
Study Record Dates
First Submitted
June 26, 2024
First Posted
August 1, 2024
Study Start
March 4, 2024
Primary Completion
August 30, 2025
Study Completion
April 30, 2026
Last Updated
August 20, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share